InflaRx (IFRX)
(Delayed Data from NSDQ)
$1.58 USD
+0.07 (4.64%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.59 +0.01 (0.63%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Cash flow Statements
Fiscal Year End for InflaRx NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -46.18 | -31.06 | -53.98 | -38.82 | -59.65 |
Depreciation/Amortization & Depletion | 0.61 | 0.63 | 0.79 | 0.81 | 0.74 |
Net Change from Assets/Liabilities | 1.09 | -10.30 | 1.82 | -6.11 | 3.80 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.55 | 5.18 | 4.12 | 2.39 | 6.71 |
Net Cash From Operating Activities | -40.92 | -35.55 | -47.25 | -41.73 | -48.39 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -19.07 | 20.57 | -30.66 | 24.51 | 23.45 |
Other Investing Activities | -0.09 | -0.17 | -0.04 | -0.11 | -0.67 |
Net Cash from Investing Activities | -19.15 | 20.40 | -30.70 | 24.40 | 22.78 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 61.39 | 2.48 | 78.27 | 11.73 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -0.40 | -0.38 | -0.43 | -0.42 | -0.33 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -3.64 | -0.05 | -4.99 | -0.83 | 0.00 |
Net Cash from Financing Activities | 57.35 | 2.04 | 72.85 | 10.48 | -0.33 |
Effect of Exchange Rate Changes | -1.05 | 2.59 | 5.43 | -1.34 | 1.01 |
Net Change In Cash & Equivalents | -3.79 | -10.52 | 0.33 | -8.18 | -24.93 |
Cash at Beginning of Period | 17.60 | 27.66 | 30.72 | 37.85 | 62.03 |
Cash at End of Period | 13.82 | 17.14 | 31.06 | 29.66 | 37.11 |
Diluted Net EPS | -0.84 | -0.71 | -1.30 | -1.44 | -2.30 |
Fiscal Year End for InflaRx NV falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -25.31 | -10.48 | -46.18 | -29.10 | -21.03 |
Depreciation/Amortization & Depletion | 0.28 | 0.13 | 0.61 | 0.47 | 0.32 |
Net Change from Assets/Liabilities | -4.00 | -5.56 | 1.09 | 0.07 | -4.68 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -0.05 | -0.23 | 3.55 | -0.76 | 1.74 |
Net Cash From Operating Activities | -29.08 | -16.14 | -40.92 | -29.32 | -23.65 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 35.50 | 29.27 | -19.07 | -22.29 | -30.39 |
Other Investing Activities | -0.03 | -0.02 | -0.09 | -0.05 | -0.03 |
Net Cash from Investing Activities | 35.47 | 29.25 | -19.15 | -22.34 | -30.41 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 0.00 | 61.39 | 61.74 | 61.85 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -0.21 | -0.09 | -0.40 | -0.30 | -0.20 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -3.64 | -3.66 | -3.66 |
Net Cash from Financing Activities | -0.21 | -0.09 | 57.35 | 57.77 | 57.98 |
Effect of Exchange Rate Changes | 0.69 | 0.37 | -1.05 | -0.21 | -0.38 |
Net Change In Cash & Equivalents | 6.88 | 13.39 | -3.79 | 5.91 | 3.54 |
Cash at Beginning of Period | 13.75 | 13.86 | 17.60 | 17.70 | 17.74 |
Cash at End of Period | 20.62 | 27.25 | 13.82 | 23.61 | 21.28 |
Diluted Net EPS | -0.26 | -0.18 | -0.28 | -0.14 | -0.15 |